Cacna2d3 activators encompass a variety of chemical compounds that play significant roles in the modulation of calcium signaling in neurons and other cell types, thus having an indirect impact on the functional activity of the Cacna2d3 protein. SNX-482, which selectively antagonizes R-type calcium channels, could inadvertently result in the upregulation of Cacna2d3-associated calcium channels, thereby potentially enhancing Cacna2d3 activity in neurons.
Agatoxin and ω-conotoxin GVIA, which hinder P/Q-type and N-type calcium channels respectively, may shift the functional burden to Cacna2d3-linked channels, thus enhancing their activity. Nimodipine, with L-type channel blocking properties, also contributes to indirect activation, allowing a greater proportional contribution of Cacna2d3 in calcium signaling. Ziconotide, another N-type channel inhibitor, further supports this trend by elevating the relative significance of Cacna2d3 in the nervous system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ω-Agatoxin IVA | 145017-83-0 | sc-302015 | 100 µg | $463.00 | ||
Agatoxin targets P/Q-type calcium channels, which can indirectly affect the function of Cacna2d3. The blockage of P/Q-type channels may enhance the significance of Cacna2d3's role in neuronal calcium signaling by shifting the functional load to Cacna2d3-associated channel subtypes. | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $61.00 $307.00 | 2 | |
Detailed Description of Cacna2d3 Activators | ||||||